Atlas of Cancer Mortality in Portugal and Spain (2003–2012)
Pablo Fernández‐Navarro, Instituto Nacional de Saúde Doutor Ricardo Jorge. Departamento de Epidemiologia. Unidade de Investigação Epidemiológica, Mario González-Sánchez, Carlos Matias Dias, Olivier Núñez(Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública), María José Bento(Universidade do Porto), Marina Pollán(Instituto de Salud Carlos III), Ana Miranda, Joana Bastos, Gonzalo López‐Abente(Instituto de Salud Carlos III), Mafalda Sousa‐Uva, Gonçalo Forjaz(Westat (United States)), Jéssica Rodrigues(IPO Porto), Virginia Lope(Instituto de Salud Carlos III), Roberto Pastor‐Barriuso(Instituto de Salud Carlos III), Beatriz Pérez‐Gómez(Instituto de Salud Carlos III), Rui Henrique(Universidade do Porto), Rita Roquette, José Dinis(Instituto Português de Oncologia Francisco Gentil), Núria Aragonés, Elena Boldo, Adela Castelló, Javier García‐Pérez, Branca Carrito, Baltazar Nunes(University of Lisbon), Nerea Fernández de Larrea, Instituto de Salud Carlos III. Centro de Investigación Biomédica en Red - CIBERESP, Rocío Carmona-Alférez, Rebeca Ramis, Raúl Rego, Ana Pais
Cited by 7
Related Papers
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
|BMJ|2017|1.8k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
Ambient Particulate Air Pollution and Daily Mortality in 652 Cities
|New England Journal of Medicine|2019|1.7k